VRTX Research Preview
1. Bottom line
- VRTX (VRTX) is trading at 479.00, with a current daily move of +0.34%.
- The StockKit strategy score is 61/100, creating a neutral research posture with bullish alignment (ma5 > ma10 > ma20 > ma60).
- The most important near-term watch zone is support at 423.23 and resistance at 535.88; price is +11.64% from support and +11.87% from resistance.
2. Key data snapshot
| Item | Reading | Interpretation |
|---|---:|---|
| Current price | 479.00 | Daily move +0.34% |
| Strategy score | 61/100 | Buy, trend: bull |
| MA structure | Bullish alignment (MA5 > MA10 > MA20 > MA60) | The short-term moving average is above the medium-term moving average, which points to a firmer near-term structure. |
| RSI14 | 58.90 | Constructive but not extreme |
| MACD | 1.74 histogram | Bullish MACD configuration |
| Support / resistance | 423.23 / 535.88 | Watch these levels for confirmation or failure |
| 30-session range | 420.01 / 533.67 | Price sits at +51.90% of the range |
| Volume check | +2.67% vs 20D avg | Confirmation quality depends on volume follow-through |
| ATR14 / price | +3.38% | Proxy for short-term volatility risk |
3. Technical indicator panel
- Trend: The short-term moving average is above the medium-term moving average, which points to a firmer near-term structure.
- Momentum: RSI14 is not giving an extreme signal, so confirmation from price structure matters more than momentum alone.
- MACD: histogram is 1.74, while MACD line / signal are 17.88 / 16.13.
- KDJ: K / D / J are 58.54 / 75.95 / 23.72; KDJ soft or still repairing.
- Bollinger: Mid-band zone (50% of band); upper / middle / lower are 535.88 / 479.55 / 423.23.
- ATR / OBV / CCI: ATR14 is 16.78 (+3.38% of price), OBV slope is +439.81%, and CCI20 is 39.78.
- Levels: estimated support / resistance are 423.23 / 535.88; recent 30-session range is 420.01 / 533.67.
4. Valuation matrix
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 31.26 | SEC EDGAR companyfacts | Medium |
| PB | 6.38 | SEC EDGAR companyfacts | Medium |
| Price / sales | 10.3 | SEC EDGAR companyfacts | Medium |
| EV/EBITDA | 26.97 | SEC EDGAR companyfacts | Low |
| PEG proxy | 5.24 | StockKit scenario model | Medium |
| StockKit fair value range | Bear $201.09 / Base $259.97 / Bull $332.79 | StockKit DCF scenario model | Medium |
| Base fair-value gap | -45.7% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear -0.03% / Base +5.97% / Bull +11.97% | StockKit scenario model | Medium |
| Revenue | $12.00B | SEC EDGAR companyfacts | High |
| Net income | $3.95B | SEC EDGAR companyfacts | High |
| Market cap | $123.58B | SEC shares outstanding + live quote | Medium |
| Balance sheet context | Assets $26.48B / Equity $19.36B | SEC EDGAR companyfacts | High |
Notes:
- SEC CIK: 0000875320; company: VERTEX PHARMACEUTICALS INC / MA.
- Latest annual income-statement period used where available: 2025-12-31.
- PEG and fair-value range are StockKit scenario outputs computed from reported fundamentals; they are not analyst consensus targets.
5. News and catalyst timeline
1. Stocks Finish Higher as Amazon Leads Megacaps Higher - Barchart.com
2. AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions - Financial Post
3. Vortex Energy Corp. Announces Marketing Program - Financial Post
4. Vortex Energy Corp. Announces Marketing Program - GlobeNewswire
6. Sentiment radar
Ticker news sentiment is Neutral (0.167) across 50 scored headlines.
| Source | Status | Reading | Confidence |
|---|
| Alpha Vantage ticker news | Connected | 23 positive / 26 neutral / 1 negative scored headlines | High |
| NewsAPI headline coverage | 5 headlines | Financial Post x2, GlobeNewswire x2, Barchart.com x1 | Medium |
| Social sentiment | Not connected | Reddit, X, StockTwits, and local forums are not configured | Low |
Notes:
- Alpha Vantage sentiment covers news/feed sentiment, not full social-channel coverage.
7. Scenario framework
| Scenario | Trigger condition | Confirmation signal | Invalidation signal |
|---|---|---|---|
| Base case | Price remains between 423.23 and 535.88 | Strategy score stays near 61/100 and RSI avoids extremes | Close below support or a rapid score deterioration |
| Upside case | Price clears 535.88 | Improving MACD histogram and volume above 20D average | Failed breakout back below resistance |
| Downside case | Price breaks 423.23 | RSI weakens and MACD remains negative | Quick recovery back above support |
8. Risk matrix
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Technical failure | Support at 423.23 anchors the current setup | Close below support | Reassess trend and reduce confidence in base case |
| Momentum exhaustion | Constructive but not extreme; MACD state: Bullish MACD configuration | RSI extension or MACD rollover | Watch next 1-3 closes and histogram direction |
| Volatility expansion | ATR14 / price is +3.38% | Wide ranges without follow-through | Require confirmation before trusting a directional move |
| News/data gap | 5 current news items available | New headline or missing catalyst context | Refresh news before relying on stale views |
9. Seven-day watch checklist
- First watch: whether price respects 423.23 or starts accepting below it.
- Breakout watch: whether price can clear 535.88 with volume confirmation above the 20-session average.
- Momentum watch: whether RSI14 stays constructive without moving into an exhaustion zone.
- Risk watch: whether fresh news changes the catalyst picture.
Strategy cross-check
| Strategy | Score | Signal | Basis |
|---|---|---|---|
| MA交叉 | 90/100 | StrongBuy | MA5>MA20金叉,多头排列 |
| MACD背离 | 70/100 | Buy | MACD金叉,MACD在零轴上方,动能减弱 |
| RSI极值 | 50/100 | Hold | RSI14=59中性 |
| 布林带 | 55/100 | Hold | 在通道中部,带宽扩张中 |
Information-use note
StockKit provides market research tools for informational and educational use. The output does not constitute personalized investment advice or a recommendation to buy, sell, or hold any security.